Instead of jumping quickly to higher doses, microdosing GLP-1 medications generally involves starting with smaller amounts or moving more gradually over time
The FDA has approved GLP-1 and related medications for chronic weight management in adults with obesity or adults with overweight and at least one weight-related condition, when used along with reduced-calorie nutrition and increased physical activity
Diabetes Care 32:14211424 Nieuwdorp M, Stroes ES, Kastelein JJ (2007) Normalization of metabolic syndrome using fenofibrate, metformin or their combination
Listen to your bodys fullness signals
This prevents jet lag confusion
Among patients who stopped taking tirzepatide, 31.0% doubled their weight loss after two years, 15.2% lost some additional weight, and 9.0% maintained their initial loss, with 55.2% in total maintaining or losing more weight